Session: Particle Formation and Crystallization Processes From Liquids, Slurries, and Emulsions I (2010 Annual Meeting)

Description:

This Session encompasses aspects of solid-liquid separation dealing with crystallization and crystal growth from solution, crystal morphology, effects of impurities, solvents and particulates, particle engineering, particle-process modeling and control, particle surface properties, interfacial effects, and emulsion crystallization. Papers covering experimental or theoretical aspects, and industrial case studies are welcome.

Sponsor:

Crystallization and Evaporation

Co-Sponsor(s):

Particle Production and Characterization (03a), Pharmaceuticals (15b)

Chair:

Fang Wang
Senior Research Scientist
Gilead Sciences
Chemical Development
333 Lakeside drive
Foster City, CA 94404
Phone Number: 650-522-2471
Email: fang.wang@gilead.com

Co-Chair:

Ranjit Thakur
Fellow
Novartis Pharma AG
Technical Research & Development
Forum1
CH-4056 Basel Phone Number: +41 61 3246254
Fax Number: +41 61 324 36 96
Email: ranjit.thakur@novartis.com

Papers:

116a

Chiral Self Assembled Monolayers as Resolving Auxiliaries in the Crystallization of Valine
Aniruddh Singh, Massachusetts Institute of Technology; Allan S. Myerson, Illinois Institute of Technology

116b

Oiling out During Crystallization Processes: Experimental Investigation and Modeling
Kai Kiesow, Technische Universität Dortmund; Feelly Ruether, Technische Universität Dortmund; Gabriele Sadowski, Technische Universität Dortmund

116c

Nanodroplet Intermediates On a Molecular Crystallization Pathway
Anna Jawor-Baczynska, University of Strathclyde; Barry D. Moore, University of Strathclyde; Jan Sefcik, University of Strathclyde

116d

Separation of Enantiomers by Coupled Preferential Crystallization - Impact of Initial Conditions On Process Performance
Matthias Johannes Eicke, Max Planck Institute for Dynamics of Complex Technical Systems; Steffen Hofmann, Technical University Berlin; Jörg Raisch, Technical University Berlin; Martin Peter Elsner, Max Planck Institute for Dynamics of Complex Technical Systems; Andreas Seidel-Morgenstern, Max Planck Institute for Dynamics of Complex Technical Systems

116e

Spherical Agglomeration – a Particle Engineering Approach in Pharmaceutical Crystallization
Chenchi Wang, Bristol-Myers Squibb Company; Chiajen Lai, Bristol-Myers Squibb Company; Shih-Ying Chang, Bristol-Myers Squibb Company; Michael Fakes, Bristol-Myers Squibb Company

116f

In-Situ Seed Generation with Wet Milling for Pharmaceutical Crystallization
Moiz Diwan, Abbott Laboratories; Hsien-Hsin Tung, Abbott Laboratories; Evelina Kim, Abbott Laboratories; Shailendra Bordawekar, Abbott Laboratories

116g

API Crystallization Process Development and Scale-up for Particle Size Control: A Case Study of a Development Candidate
Fang Wang, Gilead Sciences; Ernest Carra, Gilead Sciences; Ken Kent, Gilead Sciences; Jinyu Shen, Gilead Sciences; Pat Campbell, Gilead Sciences; Travis Lee, Gilead Sciences; Eugeniu Jurgea, Gilead Sciences; Mustapha St. Jules, Gilead Sciences; Bernard Kwong, Gilead Sciences; Zengmin Li, Gilead Sciences

See more of this Group/Topical: Separations Division

<< Previous Session | Next Session >>